BR112012016910A2 - uso do status de grupo sanguíneo ii - Google Patents

uso do status de grupo sanguíneo ii

Info

Publication number
BR112012016910A2
BR112012016910A2 BR112012016910A BR112012016910A BR112012016910A2 BR 112012016910 A2 BR112012016910 A2 BR 112012016910A2 BR 112012016910 A BR112012016910 A BR 112012016910A BR 112012016910 A BR112012016910 A BR 112012016910A BR 112012016910 A2 BR112012016910 A2 BR 112012016910A2
Authority
BR
Brazil
Prior art keywords
blood group
group status
status
blood
group
Prior art date
Application number
BR112012016910A
Other languages
English (en)
Portuguese (pt)
Inventor
Mäkivuokko Harri
Mätö Jaana
Wacklin Pirjo
Original Assignee
Suomen Punainen Risti Veripalvelu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalvelu filed Critical Suomen Punainen Risti Veripalvelu
Publication of BR112012016910A2 publication Critical patent/BR112012016910A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR112012016910A 2009-12-28 2010-12-28 uso do status de grupo sanguíneo ii BR112012016910A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20096402A FI20096402A0 (fi) 2009-12-28 2009-12-28 Veriryhmästatuksen käyttö II
US12/843,405 US20110158951A1 (en) 2009-12-28 2010-07-26 Use of blood group status ii
PCT/FI2010/051094 WO2011080396A2 (en) 2009-12-28 2010-12-28 Use of blood group status ii

Publications (1)

Publication Number Publication Date
BR112012016910A2 true BR112012016910A2 (pt) 2018-05-29

Family

ID=41462860

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012016910A BR112012016910A2 (pt) 2009-12-28 2010-12-28 uso do status de grupo sanguíneo ii

Country Status (7)

Country Link
US (1) US20110158951A1 (cg-RX-API-DMAC7.html)
EP (1) EP2519256A2 (cg-RX-API-DMAC7.html)
CN (1) CN102770154B (cg-RX-API-DMAC7.html)
BR (1) BR112012016910A2 (cg-RX-API-DMAC7.html)
FI (1) FI20096402A0 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN06392A (cg-RX-API-DMAC7.html)
WO (1) WO2011080396A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012013861A2 (en) * 2010-07-26 2012-02-02 Suomen Punainen Risti Veripalvelu Use of blood group status iii
FI20105824A0 (fi) * 2010-07-26 2010-07-26 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö IV
ES2856013T3 (es) 2013-11-15 2021-09-27 Nestle Sa Composiciones para su uso en la prevención o tratamiento de infecciones del TRS en bebés o niños jóvenes en riesgo
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20180177833A1 (en) * 2015-06-30 2018-06-28 Perfect (China) Co., Ltd. Bifidobacteria as probiotic foundation species of gut microbiota
CN105105115A (zh) * 2015-08-21 2015-12-02 暨南大学 针对abo血型人群的益生菌复合物及其方法与应用
CN113718047B (zh) * 2021-11-04 2022-02-18 艾德范思(北京)医学检验实验室有限公司 荧光定量方法检测人母乳内10属细菌的试剂盒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826928A1 (de) * 1998-06-17 1999-12-23 Novartis Consumer Health Gmbh Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
US6436451B1 (en) * 1999-03-26 2002-08-20 Eggland's Best, Inc. Method of reducing cholesterol in chicken eggs
US6613549B2 (en) * 2000-02-10 2003-09-02 Urex Biotech, Inc. Probiotic therapy for newborns
BRPI0418986A (pt) * 2004-08-05 2007-12-11 Anidral Srl cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos
MX2010002562A (es) * 2007-09-07 2011-04-11 Inst Nac De Ciencias Medicas Y Nutricion Uso de los niveles de antigeno secretor, de lewis y de sialilo como predictores para enfermedad.

Also Published As

Publication number Publication date
CN102770154A (zh) 2012-11-07
CN102770154B (zh) 2015-12-02
US20110158951A1 (en) 2011-06-30
IN2012DN06392A (cg-RX-API-DMAC7.html) 2015-10-02
EP2519256A2 (en) 2012-11-07
FI20096402A0 (fi) 2009-12-28
WO2011080396A2 (en) 2011-07-07
WO2011080396A3 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
BRPI1009197A2 (pt) preparação de ácido alfa-cetopimélico
FR2941143B1 (fr) Agrafe chirurgicale auto-agrippante
EP2480576A4 (en) PCSK9 ANTAGONISTS
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
EP2498844A4 (en) IMPFSPRITZE
PT2585437E (pt) Compostos de tioacetato, composições e métodos de uso
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BR112012021065A2 (pt) artigo de uso descartável
BRPI1010774A2 (pt) método de uso de particulados.
EP2414948A4 (en) APPLICATION SHARING
DE102010037468A8 (de) Chirurgischer Clip
EP2520259A4 (en) DIAPER
EP2498843A4 (en) CLINICAL SYRINGE
BRPI1015034A2 (pt) artigo absorvente descartável
ECSP12012034A (es) Antagonistas de pcsk9
EP2621439A4 (en) Disuposable Diaper
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
DK2246017T3 (da) Absorberende genstand
UY33094A (es) Procedimiento para la preparacion de dronedarona
EP2601921A4 (en) WAY OF CLOTHING
BRPI0913833A2 (pt) uso de corantes ácidos
BRPI1006504A2 (pt) fralda descartavel
PT2504298T (pt) Preparação e purificação de iodoxanol
DK2593060T3 (da) Engangsble
FI20095459A0 (fi) Uusia määritysmenetelmiä

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: DUPONT NUTRITION BIOSCIENCES APS. (DK)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2474 DE 05-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.